Nicotine Polacrilex USP/EP
The same resin technology behind every major nicotine gum on the market. FDA-proven controlled release.
What It Is
Nicotine bound to a polacrilin ion-exchange resin. When the resin contacts saliva, nicotine releases through pH-dependent ion exchange. This mechanism is the foundation of nicotine gum and most NRT lozenge products worldwide.
- Grades: 10% and 20% nicotine content (bound to resin)
- Form: Fine powder
- Release: pH-dependent ion exchange in the oral cavity
- Packaging: 1kg, 5kg, 10kg, 25kg, 50kg. Moisture-resistant packaging.
Who Uses This
Nicotine gum manufacturers rely on polacrilex for controlled nicotine release through chewing action. It's the most established delivery mechanism in NRT.
Lozenge producers compress polacrilex into tablets that deliver sustained nicotine as they dissolve. Predictable release curves, batch after batch.
Advanced NRT developers use the resin's controlled-release properties for novel oral nicotine formats.
What Sets This Apart
Polacrilex isn't just another nicotine form. It's a drug delivery system with decades of clinical data behind it. The resin controls how much nicotine releases and how fast. That's not something you can replicate with freebase nicotine or simple salts.
Our polacrilex meets both USP and EP monograph specifications. If you're filing with the FDA or EMA, the documentation is already built for that process.
What Ships With Every Order
- COA with nicotine content, particle size, and release profile data
- USP/EP compliance documentation
- MSDS and TDS
- Batch traceability records